The feminine touch

Article Abstract:

Surveys have shown that more women are gaining leadership roles as equity investors and exploding into the field both as entrepreneurs and investors, which could sharply improve opportunities for women and minority, led start-ups in the life sciences to tap into early-stage funding. Catherine v. Mott who is a managing partner of BlueTree Allied Angels, a group she launched in 2003 to bring individuals together to invest in early-stage companies primarily in Pittsburgh and the surrounding regions is an excellent example among burgeoning class of women who are changing the face of equity investing.

Financial management, Company investment, Investments, Businesswomen, Life sciences research

---

Can you go home again?

Article Abstract:

The abandonment of academic life in favor of biotech and then returning to academia is not a feat that faculty scientists perform easily, but many scientists have accomplished such a move. It is not easy to move easily between the two because in the past few years, industry has invested heavily in new research tools and the way research is done is so foreign to anybody in academia that industry has no need for anybody coming out of academia in the 21st century.

Drugs, Scientists, Study and teaching, Biotechnology

---

The Scientist 2006 life sciences salary survey

Article Abstract:

Abbott, Langer & Associates conducted a survey, 'Compensation of Life Scientists in the USA' and the results reflected a more favorable mix of specialists, degree levels, years of experience and geography than a year ago suggesting that salaries are gaining ground. Salaries showed a record high of 7.2% in 2006 over the prior year to a median of $74,000, compared with a 3.8% rise in the consumer price index for the 12 months ended August 2006.

Personnel administration, Biologists, Compensation and benefits, Wage surveys, Survey

Similar abstracts:

• Abstracts: The long journey home. Science goes to China. The concept of focusing Africa's science on African problems prevails across the continent
• Abstracts: Why you should be annotating: Scientists who rely on accurate gene predictions should share in the burden of creating them
• Abstracts: An archael pathogen. The big picture in microbial genomics
• Abstracts: Biotechs AIM for alternative financing: London's lesser-known stock exchange offers the possibility of money for hungry biotechs
• Abstracts: Making ethics fit: How companies are integrating ethics into their core foundation. The future of the FDA

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.